2.14

2.39% +0.05

After Hours: 2.14

Dominari Holdings Inc (DOMH)

Overview News Price History Financials Discussions Forecast Stock Split Dividend History

Dominari Holdings Inc stock is currently priced at $2.14, with a 24-hour trading volume of 4,610. It has seen a +2.39% increased in the last 24 hours and a -23.57% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $2.10 pivot point. If it approaches the $2.19 resistance level, significant changes may occur.

Previous Close:

$2.09

Open:

$2.05

24h Volume:

4,610

Market Cap:

$12.70M

Revenue:

Net Income/Loss:

$-23.22M

P/E Ratio:

-0.4289

EPS:

-4.99

Net Cash Flow:

$-21.14M

1W Performance:

+1.02%

1M Performance:

-23.57%

6M Performance:

+2.88%

1Y Performance:

-23.30%

1D Range:

$2.02

$2.2599

52W Range:

$1.76

$3.40

Dominari Holdings Inc Stock (DOMH) Company Profile

Name

Dominari Holdings Inc

Sector

Healthcare (1209)

Industry

Biotechnology (699)

Phone

703 992 9325

Address

One Rockefeller Plaza, 11th Floor, New York

Employee

Twitter

Next Earnings Date

2024-05-09

Latest SEC Filings

DOMH's Discussions on Twitter

Dominari Holdings Inc Stock (DOMH) Latest News

Analyzing Dominari (NASDAQ:DOMH) and Siebert Financial (NASDAQ:SIEB) - Defense World

Defense World

Dominari Holdings And 2 Other Stocks Under $3 Insiders Are Buying

Benzinga

Dominari Holdings And 2 Other Stocks Under $3 Insiders Are Buying - Dominari Holdings (NASDAQ:DOMH), BioR - Benzinga

Benzinga

Dominari Holdings execs buy $25k in company stock - Investing.com Nigeria

Investing.com Nigeria

DOMH Stock Quote Price and Forecast - CNN

CNN

Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance - PR Newswire

PR Newswire

Dominari Holdings Inc Stock (DOMH) Financials Data

Dominari Holdings Inc (DOMH) Net Income 2024

DOMH net income (TTM) was -$23.22 million for the quarter ending September 30, 2023, a -39.38% decrease year-over-year.

Dominari Holdings Inc (DOMH) Cash Flow 2024

DOMH recorded a free cash flow (TTM) of -$21.14 million for the quarter ending September 30, 2023, a -87.71% decrease year-over-year.

Dominari Holdings Inc (DOMH) Earnings per Share 2024

DOMH earnings per share (TTM) was -$4.48 for the quarter ending September 30, 2023, a -13.71% decline year-over-year.

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.